Cytotoxic cell populations developed during treatment with tyrosine kinase inhibitors protect autologous CD4+ T cells from HIV-1 infection-Reference-Cited by-同舟云学术

Cytotoxic cell populations developed during treatment with tyrosine kinase inhibitors protect autologous CD4+ T cells from HIV-1 infection

Published:2020-12 Issue: Volume:182 Page:114203
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Vigón Lorena,Rodríguez-Mora Sara,Luna Alejandro,Sandonís Virginia,Mateos Elena,Bautista Guiomar,Steegmann Juan Luis,Climent Nuria,Plana Montserrat,Pérez-Romero Pilar,de Ory Fernando,Alcamí José,García-Gutierrez Valentín,Planelles Vicente,López-Huertas María Rosa,Coiras Mayte

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference48 articles.

1. Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys;Whitney;Nature,2014

2. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells;Siliciano;Nat. Med.,2003

3. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: an observational study;Henrich;PLoS Med.,2017

4. Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells;Bosque;PLoS Pathog.,2011

5. Proliferation of latently infected CD4 + T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics;Hosmane;J. Exp. Med.,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dasatinib interferes with HIV-1 proviral integration and the inflammatory potential of monocyte-derived macrophages from people with HIV;Biochemical Pharmacology;2024-11

2. Primary HIV infection during chronic treatment with imatinib: impact on infection dynamics;AIDS;2024-07-11

3. Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning;Frontiers in Pharmacology;2024-06-07

4. Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19;Cancers;2023-10-20

5. Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging;Pharmaceutics;2023-03-11